Cobo Technologies ApS. (4/23/19). "News: Welcome to Our New COO, Hasse Herlevsen".

	Organisation	Cobo Technologies ApS
	Group	Cobo Technologies (Group)
	Product	PIPPR® protein expression analysis platform
	Product 2	quality control diagnostics
	Index term 2	United States (govt)–Cobo Technologies: genome editing, 201904– collab Cobo beomes member of NIST Genome Editing Consortium
	Person	Herlevsen, Hasse (Cobo Technologies 201904– COO + Co-Owner before Leo Pharma)

To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.

Hasse will be responsible for the daily operation including all internal/external QC related projects. In addition he will also lead our membership in the NIST - Genome Editing Consortium and advise customers about standards and guidelines within the CRISPR Medicine field.

Record changed: 2023-06-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Cobo Technologies (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com